Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 42 (4) , 319-329
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV CoinfectionPLOS ONE, 2013
- Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22Journal of Hepatology, 2010
- Chronic immune activation in the T cell compartment of HCV/HIV-1 co-infected patientsVirulence, 2010
- IL-22 is involved in liver regeneration after hepatectomyAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin TreatmentJournal of Virology, 2009
- Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis CGastroenterology, 2008
- CD8+T Cell Activation in Women Coinfected with Human Immunodeficiency Virus Type 1 and Hepatitis C VirusThe Journal of Infectious Diseases, 2008
- Interleukin-22 but Not Interleukin-17 Provides Protection to Hepatocytes during Acute Liver InflammationImmunity, 2007
- New approaches to fluorescence compensation and visualization of FACS dataClinical Immunology, 2004
- T-Cell Immune Activation in Children with Vertically Transmitted Hepatitis C Virus InfectionViral Immunology, 2001